American Society of
Pharmacovigilance
PRESS
ASP Announces Scientific Advisory Board
January 15th, 2019
Houston, TX
January 15th, 2019
Houston, TX
The American Society of Pharmacovigilance officially announced the members of their Scientific Advisory Board today. These individuals will play a pivotal role in advising on the direction of the organization and expanding its reach and mission. The Society aims to bring leaders in healthcare together to push the envelope in creating awareness and develop new ways of thinking to improve patient safety.
The Houston View Interviews ASP Director
November 21st, 2018
Houston, TX
The Houston View interviewed ASP Director, Sara Rogers, to discuss adverse drug events and the threat they pose to the community. Dr. Rogers was featured in an episode spotlighting professional women.
The full interview can be found at this link:
ASP Announces Official Launch
July 23rd, 2018
Houston, TX
The American Society of Pharmacovigilance announced their official launch today. The organization is founded by Benjamin Brown of Dynamic Life Sciences, MD Anderson alum, Sara Rogers and Tanner Vick of Rise Health Solutions.
The American Society of Pharmacovigilance is a national biomedical and healthcare network with membership open to all healthcare professionals. Their mission is to rapidly and dramatically reduce the high rate of suffering and mortality due to adverse drug events. The Society seeks to unify different areas of expertise and bring increased focus to fourth leading cause of death in the US.
Due to the tremendous economic burden of adverse drug events on the US healthcare system, with estimates around $136 billion annually, the Society is making plans for accelerated action in developing their programs. Their programming includes educational and awareness initiatives, development of an open access journal in pharmacovigilance, leveraging tools and technologies that can aid in the tracking, monitoring and prevention of adverse drug events as well as strategic collaborations with health systems around the US.
The Executive Director of the American Society of Pharmacovigilance, Benjamin Brown, is available for interviews. To learn more, please visit www.stopADR.org